This page shows the latest Harvard Medical School news and features for those working in and with pharma, biotech and healthcare.
Researchers from Harvard Medical School and Massachussetts General Hospital have revealed which drugs could be potentially repurposed as possible treatments for Alzheimer’s disease using artificial intelligence (AI). ... substantial resources, making
Currently, Foralumab is in a phase 1 trial at the Harvard Medical School to study its effects on neurodegenerative disease through nasal delivery.
George Church. Co-founder and Harvard Medical School genomic professor George Church says the approach means those who volunteer can benefit from having information about their genome, but still have ownership ... Our goal is to spearhead a more
Howard Weiner at Brigham and Women’s Hospital and Harvard Medical School.
Hospital and Harvard Medical School.
The three-year-old company’s ncRNA platform stems from the work of its four founding scientists – Richard Gregory, Frank Slack, Piotr Sliz and George Daley, all from Harvard Medical School
More from news
Approximately 1 fully matching, plus 37 partially matching documents found.
As expressed by Professor George Demetri of the Dana- Farber Cancer Institute and Harvard Medical School: “There’s a remarkable need for better communications, both about and around the issues in ... They have to keep up. Communicating this is almost
To answer this question, we partnered with researchers at Brigham and Women's Hospital, Harvard Medical School, and Partners HealthCare System to conduct a pilot study on the differences and similarities ... These posts are collected using a patented
Chief medical officer and president of global development Sef Kurstjens explains: “Some of the diversity we get is through one effect - that we have a global portfolio, as well as a ... But partnerships, as is so often the case, will be key, and it's
It sent dollar sign shockwaves across the US and caused a dip in faith in the medical profession and pharmaceutical companies. ... A report from Harvard Medical School found that 88% of $76.7m paid by the pharmaceutical industry to Massachusetts
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
information is of pivotal importance for the companies, the central authorities, and also for medical specialists, scientists and patients.". ... She completed her post-doctoral training at Harvard Medical School and has spent over eight years working
Leo Pharma boosts Translational Medicine team. Adam Raff will soon join dermatology-focused Leo Pharma, heading up the company’s new Translational Medicine Unit as director and medical advisor. ... Raff currently works as a dermatologist at the
Meanwhile, Dr Carl joins Big Health as medical director, bringing nearly 10 years of experience in clinical research and treatment of mental health conditions in adults. ... She has held research positions at Harvard Medical School, UCSF Medical Center,
Stockholm-based Sobi has appointed Dr Armin Reininger as a senior vice president and head of global medical and scientific affairs. ... Prior to this, Dr Reininger held several academic research and clinical positions at the Ludwig Maximillian University
Dr Isacson joins the pharma giant from Harvard Medical School, where he is a professor of neurology, and will continue to serve in an educational role while at Pfizer. ... Having first joined Harvard in 1989, Dr Isacson's work in neurogenerative disorders
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Dr Silvana Bardelli, Senior Medical Writer, has a PhD in human molecular genetics and completed her post-doctoral research at Harvard Medical School. ... emotive is an award-winning healthcare communications agency working with leading global life
as a senior medical writer. . Silvana completed her post-doctoral training at Harvard Medical School, and has spent over 7 years working across a broad variety of research, regulatory, quality assurance, ... and medical writing roles at scientific
A "must read" for anyone involved with moving their organization toward integrated care.’Joel S.Weissman, Harvard Medical School, USA.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...